Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Which regions drove dupixent's q4 2020 sales growth?

See the DrugPatentWatch profile for dupixent

Which regions drove Dupixent’s Q4 2020 sales growth?

Dupixent’s reported Q4 2020 sales growth was driven by the United States and several international markets, with the strongest contribution coming from continued momentum in the U.S. and growth outside the U.S. as well. [1]

How did U.S. vs. international performance contribute?

Across Q4 2020, management reported that U.S. gains continued alongside international growth, meaning the overall quarter’s increase was not limited to a single geography. [1]

Did any specific non-U.S. regions stand out?

The company attributed the international portion of the growth broadly to ex-U.S. markets rather than isolating one country as the sole driver for the quarter. [1]

Sources

  1. https://www.regeneron.com/investors/press-releases/2021/02-05-2021-11-19-26-572


Other Questions About Dupixent :

Dupixent end of patents? In what ways did the regional sales team's efforts impact dupixent's q4 2020 sales? Dupixent copd? Dupixent patent life? Is there a generic dupixent? In what ways did the regional sales team s efforts impact dupixent s q4 2020 sales? Is dupixent still a clinical trials?